Guided Therapeutics, Inc.
GTHP
$0.105
-$0.0038-3.49%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 388.00K | 194.00K | 275.00K | 445.00K | 591.00K |
Total Receivables | 3.00K | 2.00K | 2.00K | 7.00K | 7.00K |
Inventory | 633.00K | 636.00K | 632.00K | 632.00K | 632.00K |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 173.00K | 211.00K | 112.00K | 156.00K | 163.00K |
Total Current Assets | 1.20M | 1.04M | 1.02M | 1.24M | 1.39M |
|
|||||
Total Current Assets | 1.20M | 1.04M | 1.02M | 1.24M | 1.39M |
Net Property, Plant & Equipment | 164.00K | 189.00K | 213.00K | 237.00K | 259.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 17.00K | 17.00K | 17.00K | 17.00K | 17.00K |
Total Assets | 1.38M | 1.25M | 1.25M | 1.49M | 1.67M |
|
|||||
Total Accounts Payable | 2.13M | 2.13M | 2.18M | 1.95M | 2.02M |
Total Accrued Expenses | 784.00K | 735.00K | 630.00K | 602.00K | 840.00K |
Short-term Debt | 139.00K | 1.35M | 1.22M | 24.00K | 59.00K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.91M | 855.00K | 731.00K | 1.84M | 1.24M |
Total Finance Division Other Current Liabilities | 1.19M | 956.00K | 970.00K | 926.00K | 652.00K |
Total Other Current Liabilities | 1.19M | 956.00K | 970.00K | 926.00K | 652.00K |
Total Current Liabilities | 6.16M | 6.03M | 5.73M | 5.34M | 4.81M |
|
|||||
Total Current Liabilities | 6.16M | 6.03M | 5.73M | 5.34M | 4.81M |
Long-Term Debt | 63.00K | 66.00K | 82.00K | 34.00K | 511.00K |
Short-term Debt | 139.00K | 1.35M | 1.22M | 24.00K | 59.00K |
Capital Leases | 49.00K | 76.00K | 104.00K | 130.00K | 155.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 6.27M | 6.17M | 5.92M | 5.51M | 5.48M |
|
|||||
Common Stock & APIC | 145.95M | 145.20M | 144.76M | 144.66M | 144.42M |
Retained Earnings | -153.71M | -153.01M | -152.32M | -151.56M | -151.12M |
Treasury Stock & Other | -132.00K | -132.00K | -132.00K | -132.00K | -132.00K |
Total Common Equity | -7.89M | -7.94M | -7.69M | -7.03M | -6.83M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 3.00M | 3.02M | 3.02M | 3.02M | 3.02M |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 3.00M | 3.02M | 3.02M | 3.02M | 3.02M |
|
|||||
Total Common Equity | -7.89M | -7.94M | -7.69M | -7.03M | -6.83M |
Total Preferred Equity | 3.00M | 3.02M | 3.02M | 3.02M | 3.02M |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -4.89M | -4.92M | -4.67M | -4.01M | -3.81M |
|